Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jeffrey Olson

Concepts (319)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vitreous Body
14
2020
122
2.800
 Why?
Ophthalmologic Surgical Procedures
5
2017
84
1.990
 Why?
Angiogenesis Inhibitors
11
2022
230
1.890
 Why?
Retina
11
2016
314
1.590
 Why?
Eye Foreign Bodies
5
2016
26
1.510
 Why?
Glaucoma
4
2017
241
1.500
 Why?
Alloys
4
2013
38
1.500
 Why?
Macular Edema
4
2022
46
1.450
 Why?
Retinal Detachment
6
2019
74
1.420
 Why?
Vitrectomy
7
2019
78
1.380
 Why?
Glaucoma Drainage Implants
3
2016
45
1.330
 Why?
Diabetic Retinopathy
6
2019
201
1.320
 Why?
Retinal Diseases
5
2017
96
1.160
 Why?
Intraocular Pressure
7
2017
315
1.150
 Why?
Nanopores
2
2020
10
1.140
 Why?
Intravitreal Injections
7
2022
60
1.110
 Why?
Membranes, Artificial
2
2020
74
1.100
 Why?
Nanotechnology
2
2020
124
1.040
 Why?
Suction
3
2015
32
0.960
 Why?
Sutures
3
2015
60
0.910
 Why?
Anterior Eye Segment
2
2017
11
0.890
 Why?
Choroidal Neovascularization
4
2011
57
0.890
 Why?
Suture Techniques
3
2015
128
0.870
 Why?
Swine
10
2017
812
0.870
 Why?
Equipment Design
6
2017
525
0.850
 Why?
Lens Implantation, Intraocular
2
2015
67
0.820
 Why?
Retinitis
1
2022
21
0.760
 Why?
Retinal Vasculitis
1
2022
10
0.760
 Why?
Aneurysm
1
2022
36
0.740
 Why?
Vitreoretinopathy, Proliferative
2
2019
14
0.700
 Why?
Vascular Endothelial Growth Factor A
6
2020
554
0.680
 Why?
Antibodies, Monoclonal
6
2020
1474
0.670
 Why?
Durapatite
1
2020
36
0.660
 Why?
Retinal Vessels
2
2015
75
0.650
 Why?
Cytomegalovirus Retinitis
2
2013
21
0.640
 Why?
Isoxazoles
2
2013
54
0.640
 Why?
Eye Injuries, Penetrating
3
2016
20
0.630
 Why?
Scleral Buckling
3
2012
18
0.630
 Why?
Immunosuppressive Agents
3
2013
855
0.630
 Why?
Complement System Proteins
2
2020
333
0.630
 Why?
Endophthalmitis
2
2017
45
0.620
 Why?
Disease Models, Animal
8
2020
4421
0.610
 Why?
Stents
2
2013
531
0.580
 Why?
Fluorocarbons
2
2012
134
0.550
 Why?
Glucocorticoids
2
2020
534
0.530
 Why?
Anterior Chamber
1
2017
26
0.530
 Why?
Transducers
1
2017
27
0.530
 Why?
Sclera
2
2015
38
0.500
 Why?
Filtering Surgery
1
2016
22
0.500
 Why?
Strabismus
1
2017
65
0.500
 Why?
Trabeculectomy
1
2017
74
0.490
 Why?
Surgical Instruments
2
2013
51
0.490
 Why?
Fovea Centralis
2
2006
23
0.480
 Why?
Retinal Perforations
2
2005
19
0.470
 Why?
Drug Resistance, Multiple, Viral
2
2013
10
0.470
 Why?
Ocular Hypertension
1
2016
67
0.470
 Why?
Lenses, Intraocular
1
2015
45
0.460
 Why?
Laser Therapy
1
2017
128
0.460
 Why?
Ophthalmology
2
2013
105
0.460
 Why?
Monitoring, Physiologic
1
2017
285
0.450
 Why?
Lasers
1
2015
130
0.450
 Why?
Prostheses and Implants
1
2016
144
0.440
 Why?
Device Removal
1
2016
141
0.440
 Why?
Ischemia
2
2017
415
0.430
 Why?
Antiviral Agents
2
2013
747
0.420
 Why?
Tomography, Optical Coherence
7
2015
257
0.420
 Why?
Rabbits
3
2020
754
0.410
 Why?
Models, Cardiovascular
1
2015
197
0.410
 Why?
Fluorescein Angiography
9
2012
175
0.410
 Why?
Retinal Degeneration
2
2015
39
0.400
 Why?
Artificial Lens Implant Migration
1
2013
3
0.400
 Why?
Viscosupplements
1
2012
11
0.390
 Why?
Gravitation
1
2012
19
0.390
 Why?
Animals
18
2020
37749
0.390
 Why?
Choroid
3
2015
78
0.390
 Why?
Macular Degeneration
6
2015
186
0.380
 Why?
Silicon
1
2012
21
0.380
 Why?
Pupil Disorders
1
2012
7
0.380
 Why?
Eye Enucleation
1
2012
15
0.380
 Why?
Silicone Oils
1
2012
32
0.380
 Why?
Iris
1
2012
22
0.380
 Why?
Quantum Dots
1
2012
38
0.380
 Why?
Silicone Elastomers
1
2012
7
0.370
 Why?
Viremia
1
2013
150
0.370
 Why?
Uveitis, Posterior
1
2012
12
0.370
 Why?
Prosthesis Implantation
1
2013
157
0.370
 Why?
Surgical Stapling
1
2012
16
0.370
 Why?
Fluocinolone Acetonide
1
2012
15
0.360
 Why?
Vitreous Hemorrhage
2
2015
9
0.360
 Why?
Electric Stimulation Therapy
1
2012
81
0.360
 Why?
Cataract Extraction
1
2013
106
0.350
 Why?
Vascular Endothelial Growth Factors
1
2011
80
0.350
 Why?
Models, Biological
4
2015
1828
0.340
 Why?
Materials Testing
1
2012
354
0.320
 Why?
Cytomegalovirus
2
2013
163
0.320
 Why?
Oxygen
1
2015
992
0.310
 Why?
Humans
47
2022
141754
0.300
 Why?
Anti-Inflammatory Agents
1
2012
482
0.280
 Why?
Interleukin 1 Receptor Antagonist Protein
1
2009
255
0.280
 Why?
Biocompatible Materials
1
2012
428
0.270
 Why?
Electroretinography
5
2016
51
0.270
 Why?
von Hippel-Lindau Disease
1
2007
12
0.260
 Why?
Injections
5
2012
191
0.260
 Why?
Pigment Epithelium of Eye
2
2006
36
0.260
 Why?
Puerperal Disorders
1
2007
33
0.250
 Why?
Recombinant Fusion Proteins
4
2022
674
0.250
 Why?
Drug Implants
2
2020
83
0.250
 Why?
Uveal Diseases
1
2006
6
0.250
 Why?
Ocular Hypotension
1
2006
10
0.250
 Why?
Fusobacterium Infections
1
2006
7
0.240
 Why?
Pharyngeal Diseases
1
2006
17
0.240
 Why?
Needles
2
2017
63
0.240
 Why?
Epiretinal Membrane
1
2005
8
0.240
 Why?
Ciliary Body
1
2006
40
0.240
 Why?
Telangiectasis
1
2005
8
0.240
 Why?
Rats, Inbred BN
3
2011
56
0.230
 Why?
Antibodies, Monoclonal, Humanized
6
2015
913
0.230
 Why?
Receptors, Vascular Endothelial Growth Factor
3
2022
109
0.230
 Why?
Dementia
2
2022
263
0.230
 Why?
Visual Acuity
7
2019
447
0.230
 Why?
Uveitis
1
2006
148
0.220
 Why?
Kidney Transplantation
2
2013
678
0.220
 Why?
Injections, Intraocular
2
2015
13
0.220
 Why?
Polypropylenes
2
2015
12
0.210
 Why?
Female
26
2022
75943
0.210
 Why?
Optic Atrophy
1
2022
8
0.190
 Why?
Hearing Loss, Central
1
2022
6
0.190
 Why?
Bevacizumab
6
2015
139
0.190
 Why?
Laser Coagulation
3
2012
71
0.190
 Why?
Middle Aged
17
2019
34647
0.190
 Why?
Autoimmune Diseases
1
2006
465
0.180
 Why?
Retinal Vein Occlusion
2
2015
13
0.180
 Why?
Cell Count
2
2012
326
0.180
 Why?
Rats
4
2012
5637
0.170
 Why?
Dialysis
1
2020
18
0.170
 Why?
Leukemia, Megakaryoblastic, Acute
1
2000
10
0.170
 Why?
Orbital Neoplasms
1
2000
26
0.160
 Why?
Adsorption
1
2020
154
0.160
 Why?
Time Factors
4
2017
6966
0.160
 Why?
Follow-Up Studies
5
2015
5212
0.150
 Why?
Male
21
2019
70179
0.150
 Why?
Biomarkers
2
2020
4190
0.140
 Why?
Adult
11
2022
39391
0.140
 Why?
Eye Diseases, Hereditary
1
2018
13
0.140
 Why?
Fluorescein-5-isothiocyanate
2
2009
38
0.140
 Why?
Wet Macular Degeneration
1
2019
57
0.140
 Why?
Miniaturization
2
2015
22
0.140
 Why?
Dextrans
2
2009
85
0.140
 Why?
Geographic Atrophy
1
2019
91
0.140
 Why?
Iris Diseases
1
2017
8
0.130
 Why?
Choroid Diseases
1
2017
11
0.130
 Why?
Enzyme-Linked Immunosorbent Assay
1
2019
855
0.130
 Why?
Glomerulonephritis, Membranoproliferative
1
1997
24
0.130
 Why?
Hypertension
1
2006
1254
0.130
 Why?
Dark Adaptation
2
2012
13
0.130
 Why?
Antimony
1
2016
5
0.130
 Why?
Infliximab
2
2007
111
0.130
 Why?
Dose-Response Relationship, Drug
3
2014
2064
0.120
 Why?
Pressure
1
2017
230
0.120
 Why?
Polymers
1
2020
495
0.120
 Why?
Sclerostomy
1
2015
4
0.120
 Why?
Foreign-Body Migration
1
2016
32
0.120
 Why?
Aged, 80 and over
6
2019
7923
0.120
 Why?
Gyrate Atrophy
1
2015
2
0.120
 Why?
Vitreoretinal Surgery
1
2015
5
0.120
 Why?
Equipment Failure Analysis
1
2015
131
0.110
 Why?
Vitreous Detachment
1
2015
9
0.110
 Why?
Partial Pressure
1
2015
31
0.110
 Why?
Treatment Outcome
9
2016
11181
0.110
 Why?
Hemoglobin SC Disease
1
2015
14
0.110
 Why?
Stress, Mechanical
1
2017
489
0.110
 Why?
Diagnostic Techniques, Ophthalmological
1
2015
50
0.110
 Why?
Eye Infections, Bacterial
1
2015
45
0.110
 Why?
Biopsy, Needle
1
2015
187
0.110
 Why?
Prosthesis Failure
1
2016
125
0.110
 Why?
Feedback
1
2015
179
0.110
 Why?
Health Knowledge, Attitudes, Practice
2
2014
1406
0.110
 Why?
Aged
10
2020
24746
0.110
 Why?
International Normalized Ratio
1
2014
48
0.110
 Why?
Oculomotor Muscles
1
2014
75
0.110
 Why?
Protein Binding
1
2020
2242
0.110
 Why?
Exchange Transfusion, Whole Blood
1
2013
16
0.100
 Why?
In Vitro Techniques
1
2015
1094
0.100
 Why?
Retinal Artery Occlusion
1
2013
10
0.100
 Why?
Tendons
1
2014
123
0.100
 Why?
Postoperative Care
1
2015
280
0.100
 Why?
Down Syndrome
1
2000
506
0.100
 Why?
Warfarin
1
2014
153
0.100
 Why?
Specific Gravity
1
2012
11
0.100
 Why?
Transducers, Pressure
1
2012
12
0.100
 Why?
Diabetes Mellitus, Type 2
2
2012
2537
0.100
 Why?
Adaptation, Ocular
1
2012
6
0.100
 Why?
Rats, Mutant Strains
1
2012
24
0.100
 Why?
Erythrocyte Transfusion
1
2015
208
0.100
 Why?
Minerals
1
2012
44
0.100
 Why?
Metabolomics
1
2018
704
0.100
 Why?
Viscosity
1
2012
93
0.100
 Why?
Pupil
1
2012
22
0.090
 Why?
Acetates
1
2012
82
0.090
 Why?
Research Design
1
2019
1146
0.090
 Why?
Corneal Endothelial Cell Loss
1
2012
2
0.090
 Why?
Antineoplastic Agents
2
2020
2169
0.090
 Why?
Sodium Chloride
1
2012
140
0.090
 Why?
Endothelium, Corneal
1
2012
17
0.090
 Why?
Retinal Neovascularization
1
2012
28
0.090
 Why?
Electrodes, Implanted
1
2012
113
0.090
 Why?
Swine, Miniature
1
2012
90
0.090
 Why?
Tumor Necrosis Factor-alpha
2
2007
1250
0.090
 Why?
Microsurgery
1
2012
78
0.090
 Why?
Bruch Membrane
1
2011
6
0.090
 Why?
Gold
1
2012
119
0.090
 Why?
Drug Combinations
1
2012
368
0.090
 Why?
Retinal Ganglion Cells
1
2012
117
0.090
 Why?
Polyglycolic Acid
1
2011
44
0.090
 Why?
Adolescent
4
2019
22130
0.090
 Why?
Administration, Oral
1
2013
803
0.080
 Why?
Drug Compounding
1
2011
104
0.080
 Why?
Dissection
1
2011
55
0.080
 Why?
Registries
1
2019
2144
0.080
 Why?
Delayed-Action Preparations
1
2011
177
0.080
 Why?
Computer Simulation
1
2015
1015
0.080
 Why?
Models, Animal
1
2012
396
0.080
 Why?
Atrial Fibrillation
1
2014
384
0.080
 Why?
Anemia, Sickle Cell
1
2013
268
0.080
 Why?
Lactic Acid
1
2011
303
0.080
 Why?
Cell Survival
1
2012
1134
0.070
 Why?
Retrospective Studies
8
2015
16374
0.070
 Why?
Bacteria
1
2015
881
0.070
 Why?
Scotoma
1
2008
7
0.070
 Why?
Proliferating Cell Nuclear Antigen
1
2007
53
0.070
 Why?
Optic Neuropathy, Ischemic
1
2007
31
0.070
 Why?
Papilledema
1
2007
42
0.060
 Why?
Severity of Illness Index
2
2014
2903
0.060
 Why?
Visual Fields
3
2007
115
0.060
 Why?
RNA, Catalytic
1
2007
189
0.060
 Why?
Retinitis Pigmentosa
1
2006
20
0.060
 Why?
Glycogen Storage Disease Type IIb
1
2006
24
0.060
 Why?
Triamcinolone Acetonide
1
2006
19
0.060
 Why?
Fusobacterium necrophorum
1
2006
2
0.060
 Why?
Pilot Projects
1
2012
1826
0.060
 Why?
Polyethylene Glycols
1
2011
641
0.060
 Why?
Vision, Low
3
2013
17
0.060
 Why?
Indocyanine Green
1
2005
41
0.060
 Why?
Myopia
1
2006
55
0.060
 Why?
Coloring Agents
1
2005
96
0.060
 Why?
Eye Injuries
1
2006
53
0.060
 Why?
Infusions, Intravenous
1
2006
417
0.060
 Why?
Staining and Labeling
1
2005
154
0.060
 Why?
Syndrome
1
2006
378
0.060
 Why?
Young Adult
2
2019
13749
0.060
 Why?
Cataract
1
2006
223
0.050
 Why?
Multivariate Analysis
2
2019
1498
0.050
 Why?
Diagnosis, Differential
1
2007
1502
0.050
 Why?
Ranibizumab
2
2013
21
0.050
 Why?
Blindness
2
2013
49
0.040
 Why?
Exophthalmos
1
2000
19
0.040
 Why?
Keratitis
1
2000
22
0.040
 Why?
Chronic Disease
1
2006
1820
0.040
 Why?
Postoperative Complications
1
2012
2821
0.040
 Why?
Immunophenotyping
1
2000
329
0.040
 Why?
Xanthine
1
2018
7
0.040
 Why?
Tomography, X-Ray Computed
2
2016
2765
0.030
 Why?
Combined Modality Therapy
2
2013
1249
0.030
 Why?
Electrooculography
1
1997
12
0.030
 Why?
Color Vision Defects
1
1997
9
0.030
 Why?
Visual Field Tests
1
1997
32
0.030
 Why?
Purines
1
2018
182
0.030
 Why?
Fundus Oculi
1
1997
86
0.030
 Why?
Odds Ratio
1
2019
1057
0.030
 Why?
Cohort Studies
2
2019
5815
0.030
 Why?
Photic Stimulation
1
1997
256
0.030
 Why?
Child
2
2015
22414
0.030
 Why?
Microbiological Techniques
1
2015
33
0.030
 Why?
Vision Disorders
1
1997
168
0.030
 Why?
Endotamponade
1
2015
3
0.030
 Why?
Colony Count, Microbial
1
2015
123
0.030
 Why?
Myopia, Degenerative
1
2015
4
0.030
 Why?
Tenon Capsule
1
2014
3
0.030
 Why?
Tissue Adhesions
1
2015
33
0.030
 Why?
Mass Spectrometry
1
2018
740
0.030
 Why?
Metabolome
1
2018
366
0.030
 Why?
Photography
1
2015
115
0.030
 Why?
Conjunctiva
1
2014
53
0.030
 Why?
Atrophy
1
2015
197
0.030
 Why?
Biometry
1
2014
70
0.030
 Why?
Disease Progression
2
2015
2800
0.030
 Why?
Pregnancy
1
2007
7092
0.030
 Why?
Glucose
1
2018
1041
0.020
 Why?
Fatty Acids, Omega-3
1
2014
142
0.020
 Why?
Risk Factors
2
2019
10482
0.020
 Why?
Retreatment
1
2012
73
0.020
 Why?
Risk Assessment
2
2014
3508
0.020
 Why?
Kaplan-Meier Estimate
1
2014
910
0.020
 Why?
Oxidative Stress
1
2018
1334
0.020
 Why?
Survival Analysis
1
2014
1320
0.020
 Why?
Proportional Hazards Models
1
2014
1268
0.020
 Why?
Global Health
1
2014
387
0.020
 Why?
Phenotype
1
2019
3177
0.020
 Why?
Health Care Costs
1
2014
427
0.020
 Why?
Antioxidants
1
2014
599
0.020
 Why?
Clinical Trials, Phase II as Topic
1
2009
76
0.020
 Why?
Clinical Trials, Phase I as Topic
1
2009
53
0.020
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
454
0.020
 Why?
Anticoagulants
1
2014
675
0.020
 Why?
Comorbidity
1
2014
1664
0.020
 Why?
Colorado
1
2019
4629
0.020
 Why?
Retinal Artery
1
2007
17
0.020
 Why?
Prospective Studies
2
2012
7777
0.020
 Why?
Cerebral Angiography
1
2007
115
0.020
 Why?
Lysosomal-Associated Membrane Protein 2
1
2006
29
0.020
 Why?
Frameshift Mutation
1
2006
32
0.020
 Why?
Secondary Prevention
1
2007
241
0.020
 Why?
Infant
1
2000
9843
0.020
 Why?
Prognosis
1
2014
4080
0.010
 Why?
Anti-Bacterial Agents
1
2015
1866
0.010
 Why?
Adrenal Cortex Hormones
1
2008
501
0.010
 Why?
Double-Blind Method
1
2007
1989
0.010
 Why?
RNA, Messenger
1
2007
2828
0.010
 Why?
Aging
1
2008
1924
0.010
 Why?
Olson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (319) concept(s)
_
Co-Authors Expand Description
See all (25) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)